medRxiv preprint doi: https://doi.org/10.1101/2021.01.15.21249884; this version posted January 20, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

3

Estimating the effects of non-pharmaceutical interventions
on the number of new infections with COVID-19 during the first
epidemic wave

4

Nicolas Banholzer1 , Eva van Weenen1 , Adrian Lison1 , Alberto Cenedese1 , Arne Seeliger1 ,

5

Bernhard Kratzwald1 , Daniel Tschernutter1 , Joan Puig Salles1 , Pierluigi Bottrighi1 , Sonja

6

Lehtinen2 , Stefan Feuerriegel1 , and Werner Vach3,4,*

7

1 Department

of Management, Technology, and Economics, ETH Zurich, 8092 Zurich, Switzerland

8

2 Department

of Environmental Systems Science, ETH Zurich, 8092 Zurich, Switzerland

9

3 Basel

1

2

Academy for Quality and Research in Medicine, CH-4051 Basel, Switzerland

10

4 Department

of Environmental Sciences, University of Basel, CH-4055 Basel, Switzerland

11

* werner.vach@unibas.ch

12

Abstract
The novel coronavirus (SARS-CoV-2) has rapidly developed into a global epidemic. To control
its spread, countries have implemented non-pharmaceutical interventions (NPIs), such as school
closures, gathering bans, or even stay-at-home orders. Here we study the effectiveness of seven NPIs
in reducing the number of new infections, which was inferred from the reported cases of COVID-19
using a semi-mechanistic Bayesian hierarchical model. Based on data from the first epidemic wave
of n = 20 countries (i.e., the United States, Canada, Australia, the EU-15 countries, Norway, and
Switzerland), we estimate the relative reduction in the number of new infections attributed to each
NPI. Among the NPIs considered, event bans were most effective, followed by venue and school
closures, whereas stay-at-home orders and work bans were least effective. With this retrospective
cross-country analysis, we provide estimates regarding the effectiveness of different NPIs during the
first epidemic wave.

13

Keywords: COVID-19, coronavirus, non-pharmaceutical interventions, government interventions,

14

health-policy measures, Bayesian modeling

NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.

medRxiv preprint doi: https://doi.org/10.1101/2021.01.15.21249884; this version posted January 20, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

15

1 Introduction

16

The novel coronavirus (SARS-CoV-2) has developed into a global epidemic. Efforts to control the

17

spread of SARS-CoV-2 focused on non-pharmaceutical interventions (NPIs). These represent public

18

health-policy measures that were intended to diminish transmission rates and, to this end, aimed at

19

reducing person-to-person contacts via so-called social distancing1 . Examples include school closures,

20

venue closures, or stay-at-home orders.

21

Early studies on the population-level effects of NPIs analyzed their effectiveness mostly within a

22

single country2‚Äì9 . Thereby, NPIs were often packaged into bundles and their combined effectiveness

23

was assessed and confirmed. By combining data from multiple countries, a couple of studies have

24

attempted to compare the effectiveness of individual NPIs10‚Äì15 ; however, the evidence from these

25

studies regarding which NPIs were particularly effective is still inconclusive.

26

Here we contribute further evidence on the combined and individual effectiveness of NPIs. Using

27

a semi-mechanistic Bayesian hierarchical model, we estimated the effects of NPIs on the number of

28

new infections across n = 20 Western countries during the first epidemic wave: the United States,

29

Canada, Australia, the EU-15 countries (Austria, Belgium, Denmark, Finland, France, Germany,

30

Greece, Ireland, Italy, Luxembourg, the Netherlands, Portugal, Spain, Sweden, and the United

31

Kingdom), Norway, and Switzerland. This amounts to ‚àº3.3 million reported cases of coronavirus

32

disease 2019 (COVID-19) and covers a population of ‚àº0.8 billion people.

33

2 Methods

34

2.1 Data

35

Reported SARS-CoV-2 cases for each country between February and May 2020 were obtained from

36

the Johns Hopkins Coronavirus Resource Center, which was developed for real-time tracking of

37

reported cases of COVID-19 and directly aggregates cases recorded by local authorities in order to

38

overcome time delays from alternative reporting bodies16 . Hence, these numbers are supposed to

39

account for all COVID-19 cases identified on a specific day.

40

Data on NPIs were collected by our research team. Their implementation dates were systematically

41

obtained from government resources and news outlets before the NPIs were being classified into

42

seven categories, based on definitions applicable across our sample of countries (Tbl. 1): (1) event

2/21

medRxiv preprint doi: https://doi.org/10.1101/2021.01.15.21249884; this version posted January 20, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

43

bans, (2) school closures, (3) venue closures (e.g., shops, bars, restaurants, and venues for other

44

recreational activities), (4) gathering bans, (5) border closures, (6) stay-at-home orders prohibiting

45

public movements without valid reason, and (7) work bans on non-essential business activities. Note

46

that stay-at-home orders always also implied the presence of event bans, gathering bans and venue

47

closures as NPIs if these had not been explicitly implemented earlier.

48

The implementation date of an NPI refers to the first day a measure went into action. The

49

implementation dates were thoroughly checked to ensure correctness and consistency across countries.

50

Overall, eight authors were involved in collecting, categorizing, and checking the data. Furthermore,

51

local residents and/or native speakers were recruited from some countries in order to verify our

52

encoding in cases where the interpretation of legal terms was not ambiguous or where it was difficult

53

to distinguish, for instance, whether an NPI was enforced or recommended. Sources and details on

54

data collection for NPIs are provided in Supplement 6.
NPI
Event ban
School closure
Venue closure
Border closure
Gathering ban
Stay-at-home order
Work ban

Definition
Cancellation of mass gatherings (i.e., 50 people or more)
Closure of schools (for primary schools)
Closure of venues for recreational activities and/or shops, bars, and restaurants
Closure of national borders for individuals
Prohibition of small gatherings in public or private spaces of people from different
households
Prohibition of movement without valid reason (e.g., restricting mobility except to/from
work, local supermarkets, and pharmacies)
Closure of non-essential business activities (i.e., all businesses except supermarkets,
food suppliers, and pharmacies), thus prohibiting corresponding mobility

Table 1. List of non-pharmaceutical interventions (NPIs).

55

Our selection of Western countries defined a sample that followed a similar and comparable

56

overall strategy in controlling the COVID-19 outbreak. On the one hand, the national strategies

57

consisted of similar NPIs, which we can expect to work in a similar manner, despite cultural and

58

organisational differences between countries. On the other hand, the national strategies differed

59

in the choice, timing, and sequencing of NPIs. Taken together, the setting of this study resembles

60

that of a natural experiment, which allows us to learn about the effects of different NPIs. However,

61

in countries with a federal structure, the timing of NPIs may differ between regions (e.g., states

62

or territories). In countries with such regional variation, NPI data was collected at the regional

63

level and, similar to Hsiang et al.14 , we took into account the cumulative share of the country‚Äôs

64

population that is affected by an NPI. Fig. 1 summarizes our NPI data by comparing choice, timing

3/21

medRxiv preprint doi: https://doi.org/10.1101/2021.01.15.21249884; this version posted January 20, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

65

and sequencing of NPIs across countries after considering regional variation within countries.
a

AUS
AUT
BEL
CAN
CHE
DEU
DNK
ESP
FIN
FRA
GBR
GRC
IRL
ITA
LUX
NLD
NOR
PRT
SWE
USA
New cases
per 100k 0

5

10

15

Work ban

Stay-at-home order

Border closure

Gathering ban

Venue closure

School closure

Event ban

b

20

AUS
AUT
BEL
CAN
CHE
DEU
DNK
ESP
FIN
FRA
GBR
GRC
IRL
ITA
LUX
NLD
NOR
PRT
SWE
USA
Mar 01

Mar 15

Apr 01

Event ban

Venue closure

Border closure

School closure

Gathering ban

Stay-at-home order

Apr 15
Work ban

Figure 1. Timing of NPIs by country (ISO 3 country code). (a) Number of new cases per 100,000
(rolling 7-day mean) until NPIs were implemented across countries. For countries with regional variation
in the implementation of NPIs, the number of new cases was averaged across regions. (b) Timeline of the
implementation of NPIs. The horizontal lines show the time period in which NPIs were implemented within
each country‚Äôs regions. For most countries, there was no regional variation and the NPIs were implemented at
one day across the entire country.

66

2.2 Model summary

67

In this section, we provide a short description of our model. A detailed description, including all

68

modeling and prior choices is given in Supplement 1.

69

Fig. 2 provides a visual summary of our model structure. Our model links two unobserved

70

quantities (i.e., the daily number of contagious subjects and the daily number of new infections) to

71

an observed quantity (i.e., the number of reported new cases). The links consist of three components:

72

(1) a regression type model relating the number of new infections to the number of contagious

73

subjects, the country-specific daily transmission rate, and the presence of active measures; (2) a link

74

between the number of new infections to the number of reported new cases; and (3) a link between

75

the number of new infections and the number of contagious subjects.
4/21

medRxiv preprint doi: https://doi.org/10.1101/2021.01.15.21249884; this version posted January 20, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

For each country ùíã and day ùíï

New cases ùëµùíãùíî with ùíî ‚â• ùíï

New infections ùë∞ùíãùíî with ùíî < ùíï
3

2

Contagious subjects ùë™ùíãùíï

New infections ùë∞ùíãùíï

Effects of NPIs ùúΩ
1

School closures

Event bans

Venue closures

Gathering bans

Border
closures

Stay-at-home
orders

Work bans

Figure 2. Visual summary of the model structure: (1) the number of new infections is modelled as a function
of the number of contagious subjects, the country-specific daily transmission rate, and the reductions from
active NPIs; (2) the observed number of new cases is a weighted sum of the number of new infections in the
previous days; and (3) the number of contagious subjects is a weighted sum of the number of new infections
in the previous days.

The fundamental part of the first component is a model for the expected number ¬µ of new
infections Ijt in country j at day t. In the absence of any measure, this would be ¬µIjt = Cjt Œ¥j , where
Cjt are the number of contagious subjects and Œ¥j is the country-specific daily transmission rate. In
the presence of NPIs, we multiply this with the reduction due to avoided infections, resulting in
¬µIjt = Cjt Œ¥j ¬∑

M
Y

(1 ‚àí amjt ),

(1)

m=1

where amjt denotes the fraction of avoided infections due to NPI m = 1, . . . , M in country j at day t.
In case NPI m is implemented and fully effective, amjt is set equal to the value Œ∏m . However, an
NPI may not be fully effective in a country due to regional differences or because it may take a few
days until subjects respond to the new measures. Hence, the general structure of amjt is

amjt = Œ∏m

Rj
X

prj f (Tmrjt ),

(2)

r=1

5/21

medRxiv preprint doi: https://doi.org/10.1101/2021.01.15.21249884; this version posted January 20, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

76

where prj is region‚Äôs r = 1, . . . , Rj proportion of the total population in country j, where Tmrjt

77

denotes the number of days since the implementation of NPI m in region r of country j at time

78

t (such that Tmrjt = 1 denotes the first day at which a reduction in the number of new infections

79

could be expected), and where f (Tmrjt ) is a time-delayed response function, which is specified such

80

that the response to an NPI increases from zero on day Tmrjt = 0 to one on day Tmrjt = 3 (Fig. 3a),

81

reflecting our expectation that NPIs typically require a few days until they are fully effective. The

82

choice for the time-delayed response is varied as part of the sensitivity analysis.

83

The effect of an NPI when fully implemented is equal to Œ∏m . Within our Bayesian framework,

84

a mixture prior was used to model the effect Œ∏m . The prior consists of a half-normal distribution

85

for negative effects and a uniform distribution for positive effects (Fig. 3b). This prior allows for

86

small increases in the number of new infections with a probability of 10%, while being uninformative

87

about positive effects leading to reductions in the number of new infections.
a

b
Response

NPI becomes
fully effective

ùüè

0.75
Density

ùüé. ùüîùüî

0.50

ùüé. ùüëùüë

NPI becomes
effective

ùüé

0.25

ùüé

NPI is
implemented

ùüè
ùüê
Days since implementation (ùëªùíéùíìùíãùíï )

ùüë

-1.0

-0.5

0.0
Œ∏m

0.5

1.0

Figure 3. Modeling choices for the effects of NPIs. (a) Time-delayed response function as a first-order spline.
(b) Prior for the effects of NPIs Œ∏m .

88

In the second component, the expected number of new cases is calculated as a weighted sum of

89

the number of new infections in the previous days. The weights reflect the distribution of the time

90

from infection to reporting, and this distribution is estimated from the data assuming a log-normal

91

distribution. Informative priors are used for the parameters of the log-normal distribution, reflecting

92

prior knowledge. These priors are derived by decomposing the time from infection to reporting into

93

the incubation period and the reporting delay, thereby using a meta-analysis17 and estimates from

94

multiple studies (in particular18 ) to obtain prior information about the distributions. The observed

95

number of new cases is then modeled as a negative binomial distribution with the specified mean,

96

allowing for overdispersion. Note that this part of the overall model was only applied after the
6/21

medRxiv preprint doi: https://doi.org/10.1101/2021.01.15.21249884; this version posted January 20, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

97

day when a country reached 100 reported cumulative cases (called the modeling phase), in order to

98

avoid modeling of highly irregular case numbers in the very early stages of the epidemic when most

99

countries still had to set up their reporting practices. At the preceding days (called non-modeling

100

phase), only the other two components of the model were used (i.e., the number of new infections

101

and contagious subjects).

102

In the third component, the number of contagious subjects is calculated as a weighted sum of

103

the number of new infections in the previous days. The weights reflect the probability of being

104

contagious on a specific day after being infected and can be determined from the generation time

105

distribution. This distribution is assumed to be known and our choice is based on an estimate by a

106

recent study using data on the exposure for both the index and secondary case19 .

107

2.3 Parameter estimation

108

Choices of priors not mentioned so far are weakly informative, following general recommendations in

109

Bayesian modeling20 . All model parameters are estimated with a semi-mechanistic Bayesian hierar-

110

chical model. Specifically, Markov chain Monte Carlo (MCMC) sampling is used as implemented by

111

the Hamiltonian Monte Carlo algorithm with the No-U-Turn Sampler (NUTS) from the probabilistic

112

programming language Stan, version 2.19.221 . Each model is estimated with 4 Markov chains and

113

2,000 iterations of which the first 1,000 iterations are discarded as part of the warm-up. Estimation

114

power is evaluated via the ratio of the effective sample size (nÃÇeff /N ), and convergence of the Markov

115

chains is assessed with the Gelman-Rubin convergence diagnostic (RÃÇ). Further checks pertain to the

116

detection of influential observations and correlations between the parameters of interest. If not stated

117

otherwise, we report posterior means and credible intervals (CrIs) based on the 2.5% and 97.5%

118

quantile of the posterior samples. Detailed estimation results and model diagnostics are provided in

119

Supplement 3. The sensitivity of the results to the following modeling choices was investigated:

120

start and end of the modeling phase, time-delayed response function, prior distribution for the effect

121

of an NPI Œ∏m , prior choices for the time from infection to reporting and for the generation time.

122

Furthermore, the sensitivity of the results with respect to exclusion of individual countries was

123

assessed with a leave-one-country-out analysis. Finally, a comparison to a similar study that was

124

recently published11 is presented.

7/21

medRxiv preprint doi: https://doi.org/10.1101/2021.01.15.21249884; this version posted January 20, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

125

2.4 Data and code availability

126

We collected data from publicly available data sources (Johns Hopkins Coronavirus Resource Center16

127

for epidemiological data; news reports and government resources for policy measures). All the

128

public health information that we used is documented in the main text, the extended data, and

129

supplementary tables. A preprocessed data file together with reproducible code is available from

130

https://github.com/nbanho/npi_effectiveness_first_wave.

131

3 Results

132

3.1 Estimated effects of NPIs

133

Using data from the first epidemic wave, we estimated the relative reduction in the number of

134

new infections for each NPI (Fig. 4a). Event bans were associated with the highest reduction in

135

the number of new infections (37 %; 95% CrI 21 % to 50 %). The reduction was lower for venue

136

closures (18 %; 95% CrI ‚àí4 % to 40 %) and school closures (17 %; 95% CrI ‚àí2 % to 36 %), followed

137

by border closures (10 %; 95% CrI ‚àí2 % to 21 %) and gathering bans (9 %; 95% CrI ‚àí4 % to 23 %).

138

stay-at-home orders (4 %; 95% CrI ‚àí6 % to 17 %) and work bans on non-essential business activities

139

(1 %; 95% CrI ‚àí8 % to 12 %) appeared to be the least effective among the NPIs considered in this

140

analysis.

141

The estimates for the individual effects suggest a particular strong effect of event bans. This result

142

is further supported by analyzing the posterior ranking of the effects (Fig. 4b), which indicates that

143

we could be at least 98 % sure that event bans were among the two most effective NPIs. Conversely,

144

we could be at least 76 % sure that work bans were among the two least effective NPIs.

145

All NPIs together lead to an estimated relative reduction in the number of new infections by

146

67 % (95% CrI 64 % to 71 %). The combined effectiveness of NPIs was also analyzed (Fig. 4c-d).

147

Thereby, we could be at least 97 % sure that at least five NPIs simultaneously lead to a reduction in

148

the number of new infections. Regarding the magnitude of the effects, we could be at least 91 %

149

sure that three NPIs simultaneously lead to a reduction in the number of new infections of more

150

than 10 %.

8/21

medRxiv preprint doi: https://doi.org/10.1101/2021.01.15.21249884; this version posted January 20, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

a

b

Event ban
Venue closure
School closure
Border closure
Gathering ban
Stay-at-home order
Work ban

Event ban
Venue closure
School closure
Border closure
Gathering ban
Stay-at-home order
Work ban
0
0

25
50
Estimated reduction (%)

25
50
75
Estimated proportion (%)

Rank

1

2

3

4

5

6

100
7

d
24

7
6
5
4
3
2
1
0

25

76

50
75
Estimated proportion (%)

97
100
100
100
100
100

m effects > 10%

m effects > 0%

c

75

0
1

7
6
5
4
3
2
1
0

14

56

25

50
75
Estimated proportion (%)

91

100
100

100

Figure 4. Estimated effects of NPIs. (a) Reduction in new infections (posterior mean as dots with 80%
and 95% credible interval as thick and thin lines, respectively). (b) Ranking of the effects of NPIs from
highest (1) to lowest (7) (posterior frequency distribution). (c) Frequency of at least m positive effects
(posterior frequency distribution). (d) Frequency of at least m effects greater than 10 % (posterior frequency
distribution).

151

3.2 Sensitivity analysis

152

Sensitivity of our results was assessed with respect to varying modeling and prior choices (Supplement

153

4). Overall, our results were only slightly sensitive to alternative modeling and prior choices,

154

particularly when deriving conclusions about the ranking of the effects. A leave-one-out analysis for

155

the countries in our sample indicated some sensitivity with respect to the exclusion of Australia,

156

Sweden, and Switzerland. This sensitivity was further investigated and subsequent analysis indicated

157

that data from these countries are particularly informative for the effect of school closures and event

158

bans.

159

3.3 Estimated number of new infections and cases over time

160

The model fit was assessed by comparing the expected number of new cases based on our model

161

to the observed number of new cases (Fig. 5). Here an acceptable degree of agreement is observed

162

for Australia, Germany, Sweden, the UK, and all other countries (figures for all other countries are

9/21

medRxiv preprint doi: https://doi.org/10.1101/2021.01.15.21249884; this version posted January 20, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

163

listed in Supplement 5). In addition, the posterior distribution for the number of new infections is

164

depicted, illustrating how NPIs lead to a reduction in new infections, which later implies a reduction

165

in new cases.

166

3.4 Comparison with a similar study

167

Recently, an analysis similar to our was published by Brauner et al.11 . In the following, we present a

168

brief comparison. Brauner et al. used the same data source to generate country-specific case numbers

169

per day, but included 30 countries only partially overlapping with our selection. The authors used

170

similar sources to collect data on NPIs but classified some NPIs differently. The modeling approach

171

was very similar, except for avoiding to take the number of contagious subjects explicitly into account

172

and considering both the number of reported cases and reported deaths as outcomes. The authors

173

included country-specific NPI effects (although not explicitly analyzed), while we took into account

174

the share of the country‚Äôs total population being affected by NPIs and a time-delayed response to

175

their implementation. The authors used similar priors for the distribution of the time from infection

176

to reporting and for the generation time distribution, but estimated the latter explicitly as part of

177

fitting the model.

178

To facilitate a comparison of the results between the modeling approach by Brauner et al. and

179

our approach, we reanalyzed their data using our model. The estimated effects from our model were

180

generally smaller but the overall ranking of the effects was very similar when fitted to the same data

181

(Tbl. 2a). In contrast to that, when comparing the results from our model on different datasets (our

182

data and the data from Brauner et al.), there was only a similarity in the overall pattern (Tbl. 2b).

183

For instance, we found similar strong effects for event bans and school closures as well as weak

184

effects for stay-at-home orders, but the effect of venue closures is stronger and the effect of work

185

bans weaker in our data. In addition, the larger set of countries in the data from Brauner et al. was

186

associated with smaller credible intervals for the estimates.

187

4 Discussion

188

4.1 Estimated NPI effects

189

We performed a cross-country analysis based on n = 20 countries in order to assess the effectiveness

190

of seven NPIs during the first epidemic wave. Our findings suggest that some NPIs, particularly in

10/21

medRxiv preprint doi: https://doi.org/10.1101/2021.01.15.21249884; this version posted January 20, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

a

b
Australia

Germany

Modeling phase

S BG
E V

H

10000

Number of new cases/infections

Number of new cases/infections

600

Non-modeling

400

200

0
Feb 04 Feb 18 Mar 03 Mar 17 Mar 31 Apr 14 Apr 28
¬µI

c

Modeling phase

E GS H
V

7500

5000

2500

0
Jan 26 Feb 09 Feb 23 Mar 08 Mar 22 Apr 05 Apr 19

Observed N

¬µN

Non-modeling

¬µI

¬µN

Observed N

d
Sweden

Number of new cases/infections

Modeling phase
E

G

1500

1000

500

10000
Number of new cases/infections

Non-modeling
2000

United Kingdom

0
Jan 31 Feb 14 Feb 28 Mar 13 Mar 27 Apr 10 Apr 24
¬µI

¬µN

Observed N

Non-modeling

Modeling phase
E V

S
G
H

7500

5000

2500

0
Jan 27 Feb 10 Feb 24 Mar 09 Mar 23 Apr 06 Apr 20
¬µI

¬µN

Observed N

Figure 5. Expected number of new infections ¬µI and new cases ¬µN (posterior mean as colored lines with
95% credible interval as shaded area) and the observed number of new cases by country over time. (a-d) Time
series for four selected countries. Red letters and lines indicate the first day an NPI was implemented within
a country (S: School closures, B: Border closure, E: Event ban, G: Gathering ban, V: Venue closure, H:
stay-at-home order, W: Work ban). The non-modeling phase is the time period before 100 cumulative cases
were observed, which was used to seed infections in the early outbreak of the epidemic. Plots for all countries
are provided in Supplement 5.

191

combination, lead to a strong reduction in the number of new infections. Among the NPIs considered,

192

event bans were most effective in reducing the number of new infections across countries. Event bans
11/21

medRxiv preprint doi: https://doi.org/10.1101/2021.01.15.21249884; this version posted January 20, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Gatherings <1000
Gatherings <100
Gatherings <10
Schools and universities closed
Some businesses closed
Most businesses closed
stay-at-home order

Our model and data
by Brauner et al
Mean (CrI)
Rank
17 ( 5 ‚Äì 28)
5
24 ( 11 ‚Äì 36)
2
32 ( 17 ‚Äì 47)
1
23 ( 12 ‚Äì 34)
3
5 (‚àí 5 ‚Äì 17)
7
18 ( 5 ‚Äì 30)
4
12 ( 5 ‚Äì 18)
6

Model and data by
Brauner et al
Mean (PrI)
Rank
23 ( 0 ‚Äì 40)
5
34 ( 12 ‚Äì 42)
3
42 ( 17 ‚Äì 60)
1
38 ( 16 ‚Äì 54)
2
18 (‚àí 8 ‚Äì 40)
6
27 (‚àí 3 ‚Äì 49)
4
13 (‚àí 5 ‚Äì 31)
7

(a) Comparison of modeling.
Our model and data
Our NPI
Event bans
Venue closure
School closure
Border closure
Gathering ban
stay-at-home order
Work bans

NPI by Brauner et al.
Gatherings <1000
Some businesses closed
Schools and universities closed
Gatherings <100 + Gatherings <10
stay-at-home order
Most businesses closed

37
18
17
10
9
4
1

Mean
( 21
(‚àí 4
(‚àí 2
(‚àí 2
(‚àí 4
(‚àí 6
(‚àí 8

(CrI)
‚Äì 50)
‚Äì 40)
‚Äì 36)
‚Äì 21)
‚Äì 23)
‚Äì 17)
‚Äì 12)

Rank
1
2
3
4
5
6
7

Our model and data
by Brauner et al.
Mean (CrI)
Rank
17 ( 5 ‚Äì 28)
2
5 (‚àí 5 ‚Äì 17)
6
23 ( 12 ‚Äì 34)
1
15 (
12 (
12 (

1 ‚Äì 29)
5 ‚Äì 18)
2 ‚Äì 22)

3
5
4

(b) Comparison of data.

Table 2. Comparison of modeling and data with results from Brauner et al.11 . (a) Estimated effects by
model and data from Brauner et al. (posterior mean in %, 95% prediction interval (PrI) and rank) and by
our model and data from Brauner et al. (posterior mean in %, 95% credible interval and rank). Note that, in
these analyses, we report cumulative effects for gathering bans and businesses closed. (b) Estimated effects
by our model on our data (posterior mean in %, 95% credible interval, and rank) and by our model and data
from Brauner et al. (posterior mean in %, 95% credible interval, and rank). Similar NPIs were matched but
their definitions are not exactly the same. Note that in applying our model to the data by Brauner at al., we
report the cumulative effect of ‚Äúgatherings < 100‚Äù and ‚Äúgatherings < 10‚Äù when referring to our gathering ban.

193

are targeted towards large gatherings of people and may thus prevent so-called ‚Äúsuperspreader events‚Äú,

194

which have been shown to account for a substantial fraction of the total number of infections22‚Äì24 .

195

Many superspreading events originated in points-of-interest such as bars and restaurants25 , which

196

aligns with our finding of a sizeable reduction from venue closures.

197

The effectiveness of school closures in transmission control is subject to debate26, 27 . Although

198

children are less susceptible to the virus than adults, it is less clear how children and adults compare

199

regarding their infectiousness28 . Early findings suggested that school closures were only marginally

200

effective in transmission control29 . Our results provide contrary evidence, in line with recent findings

201

from other population-based studies11, 13, 15, 30, 31 . However, note that our findings relate to the closure

202

of primary schools, which often coincided with the closure of secondary schools and universities.

203

The study by Brauner et al. differentiated between NPIs for the closure of schools and the closure

204

of universities, but could afterwards not disentangle the estimated effects11 . Thus, it is subject

12/21

medRxiv preprint doi: https://doi.org/10.1101/2021.01.15.21249884; this version posted January 20, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

205

to further investigation whether the closure of primary schools is less effective than the closure of

206

secondary schools and universities28 .

207

A small effect was estimated for stay-at-home orders. This seems to contradict findings about

208

the high effectiveness of the lockdown from Flaxman et al.12 . However, one should consider that

209

their definition of a lockdown encompasses multiple NPIs that we differentiated (e.g., gathering bans,

210

venue closures, and stay-at-home orders). Taken together, our estimated ‚Äúlockdown effect‚Äù would

211

therefore also be large. Finally, although our findings suggest that work bans were not effective,

212

it should be considered that our definition of a work ban referred to a strict ban of non-essential

213

business activities, while many countries only issued recommendations.

214

4.2 Methodological aspects

215

Flaxman et al.12 were the first who attempted to link NPIs to observed cases or deaths using a

216

semi-mechanistic Bayesian hierarchical model. Both the study of Brauner et al.11 and our study can

217

be seen as extensions of this approach, thereby making use in particular of data from more countries.

218

This also implies the possibility of refined modeling.

219

The above studies have in common that they model the effect of the NPIs on the number of

220

new infections. Whereas the other studies approached this by modeling explicitly the effect on the

221

reproduction number, we directly modelled the number of new infections in relation to the number

222

of contagious subjects. Thereby, the generation time distribution was used in a way to approximate

223

the time from infection to becoming contagious32 .

224

A further common property of the above studies is the use of prior information on the distribution

225

of certain quantities that play a central role in the spread of infectious diseases. Flaxman et al.

226

equal the generation time distribution with the serial distribution, whereas Brauner et al. and our

227

study avoid this, considering that there can be a substantial difference between these distributions33 .

228

Brauner et al. estimated the generation time distribution from their data on cases and deaths using

229

an informative prior, whereas we made use of an explicit assumption based on prior knowledge. The

230

second quantity used in both studies is the time from infection to reporting, which is assumed to

231

be known by Flaxman et al. and estimated by Brauner et al. and our study. Similar to the other

232

studies, we investigated the sensitivity of the estimated NPI effects with respect to the assumptions

233

made or the priors chosen.

13/21

medRxiv preprint doi: https://doi.org/10.1101/2021.01.15.21249884; this version posted January 20, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

234

A specific property of our approach is to take the regional variation in the implementation of

235

NPIs explicitly into account. We approached this by incorporating the share of the country‚Äôs total

236

population that is affected by active NPIs in our model. The other studies ignored this variation

237

or restricted the analysis to countries with no or very little regional variation. A further specific

238

property was to allow for a gradual increase in the response to NPIs over the first few days, whereas

239

the other studies assumed a full response on the first day NPIs were implemented.

240

4.3 Insights from a comparison with a similar study

241

With the data on reported cases and deaths gathered by the John Hopkins University and data

242

on NPIs gathered by government and news websites, there is a unique source for analyzing the

243

impact of health policy measures on the course of the COVID-19 pandemic. However, there are

244

many degrees of freedom with respect to preprocessing the available data, constructing a model,

245

and making prior assumptions and choices. To understand the influence of these data and modeling

246

choices on the results, it is desirable that different research groups analyse the same data in different

247

ways. A very recent publication by Brauner et al.11 gave us the possibility to perform a first check

248

of this type. The check indicated that the choice of countries and definition of NPIs has a larger

249

influence on the estimated effects than the detailed choices in modeling. A re-analysis of the original

250

study by Flaxman et al. could also demonstrate sensitivity of the results with respect to specific

251

choices of the definition of NPIs, but also found sensitivity to specific modeling choices34 .

252

4.4 Limitations

253

Our analysis is subject to limitations. First, our modeling assumptions do not allow for (random)

254

variation in the effect of NPIs across countries and assume a fixed effect. Brauner et al.11 demon-

255

strated that, in principle, it is feasible to allow for country-specific variation in the effects. However,

256

the specific parametrization chosen in our model (i.e., to take into account regional variation in

257

the implementation of NPIs via the population share) made it challenging to incorporate random

258

variation of the NPI effect Œ∏m across countries. Brauner et al observed in the sensitivity analysis

259

of their study that assuming a fixed effect does not alter the main conclusions that they discussed

260

regarding the effectiveness of NPIs.

261

262

Second, any approach of explaining changes in the observed number of cases solely by specific
NPIs makes the implicit assumption that these changes were not the result of some other factors.
14/21

medRxiv preprint doi: https://doi.org/10.1101/2021.01.15.21249884; this version posted January 20, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

263

For instance, it is possible that additional measures or an increasing general awareness encouraged

264

social distancing and hence lead to less infections. If this is the case, such effects will erroneously be

265

assigned to the NPIs and possibly overstate their overall impact.

266

Third, it is challenging to distinguish between the effects of single NPIs due to their concurring

267

introduction in many countries (Supplement Tbl. 4). This is reflected by wide credible intervals

268

and a negative association between effects (Supplement Fig. 3.2), suggesting that the effect of one

269

NPI may be attributed partially to another. Note that the effect of event bans could be estimated

270

with comparably narrower credible intervals than that of venue and school closures. A reason for

271

this could be that all three measures were implemented by most countries but event bans had on

272

average a greater distance in implementation to other NPIs as compared to school and venue closures

273

(Supplement Tbl. 3). Despite the difficulty in disentangling the effects of individual NPIs, we were

274

able to demonstrate that we can be fairly confident with respect to their relative ranking.

275

Fourth, our analysis is limited by the type of data utilized to define the outcomes. Using the

276

number of reported cases as outcome implies that reporting practices may have an influence on

277

the results. In particular, definitions and reporting practices differed between countries and over

278

time. However, since we modeled the ratio between the number of new cases and the number of

279

contagious subjects, we can expect that these effects cancel out. The same argument applies to the

280

challenge that we have to expect a substantial number of undetected cases, with detection rates

281

varying across countries and over time. In addition, we modelled the number of reported cases as a

282

random variable, thereby allowing for overdispersion. Moreover, we took into account that countries

283

had still to develop their reporting practice in the very early phase of the epidemic by starting the

284

modeling phase after at least 100 cumulative cases were reported in a country.

285

Fifth, our analysis is limited by the need to classify NPIs in a comparable manner across countries

286

and to determine dates when NPIs were exactly implemented. There is always some subjectivity

287

in making corresponding decisions. The comparison of our study with the one by Brauner et al.

288

suggests that such definitions can be crucial. We provide a detailed description of our decisions

289

(Supplement 6).

15/21

medRxiv preprint doi: https://doi.org/10.1101/2021.01.15.21249884; this version posted January 20, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

290

4.5 Outlook

291

With the model presented in this paper and that developed by Brauner et al., we may have reached

292

a first level of maturity. This may be sufficient to justify the use of these models in analyzing the

293

effects of NPIs. In principle, these models could also be used to study the effect of lifting NPIs.

294

A natural next step would be to apply these models to data from the second wave, which is still

295

ongoing. An interesting question would then be whether we can expect similar effects in the first and

296

the second wave. It is likely that some effects may have changed, as the situations are not necessarily

297

comparable and experience from the first wave may have helped in dealing with the second wave.

298

Of course, there is still room for improvement and refinement of the models. If information

299

on new cases is also available at a regional level, regional variation in implementing NPIs can be

300

used as an additional source of information using a two-level hierarchical approach. Furthermore,

301

between-country and regional variation may be linked to certain characteristics which may help to

302

understand the conditions under which an NPI is most effective. Similarly, information on cases

303

stratified by patient characteristics may provide new insights. Also the modeling of the outcome can

304

be improved, e.g., by taking weekday effects into account.

305

4.6 Conclusion

306

Our analysis makes a contribution to the emerging evidence about the effectiveness of different NPIs

307

in the first epidemic wave. Event bans in particular were identified as an effective measure, whereas

308

little evidence was found for substantial effects of stay-at-home orders and work bans. A comparison

309

with another study indicates robustness of some conclusions, but also a dependence on the choice of

310

data and definitions.

311

References

312

1. World Health Organization. Coronavirus diseases (COVID-19) advice for the public; 2020.

313

Available from:

314

advice-for-public/videos.

https://www.who.int/emergencies/diseases/novel-coronavirus-2019/

315

2. Cowling BJ, Ali ST, Ng TWY, Tsang TK, Li JCM, Fong MW, et al. Impact assessment of

316

non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong:

16/21

medRxiv preprint doi: https://doi.org/10.1101/2021.01.15.21249884; this version posted January 20, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

317

an observational study. The Lancet Public Health. 2020 5;5(5):e279‚Äìe288. Available from:

318

https://linkinghub.elsevier.com/retrieve/pii/S2468266720300906.

319

3. Davies NG, Kucharski AJ, Eggo RM, Gimma A, Edmunds WJ, Jombart T, et al. Effects of

320

non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services

321

in the UK: a modelling study. The Lancet Public Health. 2020 7;5(7):e375‚Äìe385. Available from:

322

https://linkinghub.elsevier.com/retrieve/pii/S246826672030133X.

323

4. Dehning J, Zierenberg J, Spitzner FP, Wibral M, Neto JP, Wilczek M, et al. Inferring change

324

points in the spread of COVID-19 reveals the effectiveness of interventions. Science. 2020

325

7;369(6500):eabb9789. Available from: https://www.sciencemag.org/lookup/doi/10.1126/

326

science.abb9789.

327

5. Gatto M, Bertuzzo E, Mari L, Miccoli S, Carraro L, Casagrandi R, et al.

Spread and

328

dynamics of the COVID-19 epidemic in Italy:

Effects of emergency containment mea-

329

sures.

330

Available from: https://www.pnas.org/content/early/2020/04/22/2004978117http://www.

331

pnas.org/lookup/doi/10.1073/pnas.2004978117.

Proceedings of the National Academy of Sciences. 2020 5;117(19):10484‚Äì10491.

332

6. Koo JR, Cook AR, Park M, Sun Y, Sun H, Lim JT, et al. Interventions to mitigate early

333

spread of SARS-CoV-2 in Singapore: a modelling study. The Lancet Infectious Diseases. 2020

334

6;20(6):678‚Äì688. Available from: https://doi.org/10.1016/S1473-3099(20)30162-6https:

335

//linkinghub.elsevier.com/retrieve/pii/S1473309920301626.

336

7. Lai S, Ruktanonchai NW, Zhou L, Prosper O, Luo W, Floyd JR, et al. Effect of non-pharmaceutical

337

interventions to contain COVID-19 in China. Nature. 2020 9;585(7825):410‚Äì413. Available from:

338

http://www.nature.com/articles/s41586-020-2293-x.

339

8. Maier BF, Brockmann D. Effective containment explains subexponential growth in recent

340

confirmed COVID-19 cases in China. Science. 2020 5;368(6492):742‚Äì746. Available from: https:

341

//www.sciencemag.org/lookup/doi/10.1126/science.abb4557.

342

9. Prem K, Liu Y, Russell TW, Kucharski AJ, Eggo RM, Davies N, et al. The effect of control

343

strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China:

344

a modelling study. The Lancet Public Health. 2020 5;5(5):e261‚Äìe270. Available from: https:

345

//linkinghub.elsevier.com/retrieve/pii/S2468266720300736.
17/21

medRxiv preprint doi: https://doi.org/10.1101/2021.01.15.21249884; this version posted January 20, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

346

10. Banholzer N, Weenen Ev, Kratzwald B, Seeliger A, Tschernutter D, Bottrighi P, et al. Estimating

347

the impact of non-pharmaceutical interventions on documented infections with COVID-19: A

348

cross-country analysis. medRxiv. 2020 4;Available from: https://www.medrxiv.org/content/

349

10.1101/2020.04.16.20062141v3.

350

11. Brauner JM, Mindermann S, Sharma M, Johnston D, Salvatier J, Gavenƒçiak T, et al. Inferring

351

the effectiveness of government interventions against COVID-19. Science. 2020 12;p. eabd9338.

352

Available from: https://www.sciencemag.org/lookup/doi/10.1126/science.abd9338.

353

12. Flaxman S, Mishra S, Gandy A, Unwin HJT, Mellan TA, Coupland H, et al. Estimating the effects

354

of non-pharmaceutical interventions on COVID-19 in Europe. Nature. 2020 8;584(7820):257‚Äì261.

355

Available from: http://www.nature.com/articles/s41586-020-2405-7.

356

13. Haug N, Geyrhofer L, Londei A, Dervic E, Desvars-Larrive A, Loreto V, et al. Ranking the

357

effectiveness of worldwide COVID-19 government interventions. Nature Human Behaviour. 2020

358

12;4(12):1303‚Äì1312. Available from: http://www.nature.com/articles/s41562-020-01009-0.

359

14. Hsiang S, Allen D, Annan-Phan S, Bell K, Bolliger I, Chong T, et al. The effect of large-scale

360

anti-contagion policies on the COVID-19 pandemic. Nature. 2020 8;584(7820):262‚Äì267. Available

361

from: http://www.nature.com/articles/s41586-020-2404-8.

362

15. Li Y, Campbell H, Kulkarni D, Harpur A, Nundy M, Wang X, et al. The temporal as-

363

sociation of introducing and lifting non-pharmaceutical interventions with the time-varying

364

reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries. The Lancet

365

Infectious Diseases. 2020 10;Available from: https://linkinghub.elsevier.com/retrieve/

366

pii/S1473309920307854.

367

16. Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time.

368

The Lancet Infectious Diseases. 2020 5;20(5):533‚Äì534. Available from: https://linkinghub.

369

elsevier.com/retrieve/pii/S1473309920301201.

370

17. McAloon C, Collins A, Hunt K, Barber A, Byrne AW, Butler F, et al. Incubation period

371

of COVID-19: a rapid systematic review and meta-analysis of observational research. BMJ

372

Open. 2020 8;10(8):e039652. Available from: https://bmjopen.bmj.com/lookup/doi/10.1136/

373

bmjopen-2020-039652.

18/21

medRxiv preprint doi: https://doi.org/10.1101/2021.01.15.21249884; this version posted January 20, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

374

18. Cereda D, Tirani M, Rovida F, Demicheli V, Ajelli M, Poletti P, et al. The early phase of the

375

COVID-19 outbreak in Lombardy, Italy. arXiv. 2020 3;Available from: http://arxiv.org/abs/

376

2003.09320.

377

19. Ferretti L, Ledda A, Wymant C, Zhao L, Ledda V, Abeler L, et al. The timing of COVID-19

378

transmission. medRxiv. 2020 9;Available from: https://www.medrxiv.org/content/10.1101/

379

2020.09.04.20188516v2.

380

381

20. Stan Development Team. Prior Choice Recommendations; 2020. Available from: https:
//github.com/stan-dev/stan/wiki/Prior-Choice-Recommendations.

382

21. Carpenter B, Gelman A, Hoffman MD, Lee D, Goodrich B, Betancourt M, et al. Stan : A

383

Probabilistic Programming Language. Journal of Statistical Software. 2017;76(1). Available from:

384

http://www.jstatsoft.org/v76/i01/.

385

22. Adam D.

Special report:

The simulations driving the world‚Äôs response to COVID-

386

19. Nature. 2020 4;580(7803):316‚Äì318. Available from: http://www.nature.com/articles/

387

d41586-020-01003-6.

388

23. Lemieux JE, Siddle KJ, Shaw BM, Loreth C, Schaffner SF, Gladden-Young A, et al. Phylogenetic

389

analysis of SARS-CoV-2 in Boston highlights the impact of superspreading events. Science. 2020

390

12;p. eabe3261. Available from: https://www.sciencemag.org/lookup/doi/10.1126/science.

391

abe3261.

392

393

24. Wang CJ, Ng CY, Brook RH. Response to COVID-19 in Taiwan. JAMA. 2020 4;323(14):1341.
Available from: https://jamanetwork.com/journals/jama/fullarticle/2762689.

394

25. Chang S, Pierson E, Koh PW, Gerardin J, Redbird B, Grusky D, et al. Mobility network models

395

of COVID-19 explain inequities and inform reopening. Nature. 2021 1;589(7840):82‚Äì87. Available

396

from: http://www.nature.com/articles/s41586-020-2923-3.

397

26. Couzin-Frankel J. School openings across globe suggest ways to keep coronavirus at bay, despite

398

outbreaks.

Science. 2020 7;Available from: https://www.sciencemag.org/news/2020/07/

399

school-openings-across-globe-suggest-ways-keep-coronavirus-bay-despite-outbreaks.

400

27. Levinson M, Cevik M, Lipsitch M. Reopening Primary Schools during the Pandemic. New

401

England Journal of Medicine. 2020 9;383(10):981‚Äì985. Available from: http://www.nejm.org/
19/21

medRxiv preprint doi: https://doi.org/10.1101/2021.01.15.21249884; this version posted January 20, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

402

doi/10.1056/NEJMms2024920.

403

28. Goldstein E, Lipsitch M, Cevik M. On the Effect of Age on the Transmission of SARS-

404

CoV-2 in Households, Schools, and the Community. The Journal of Infectious Diseases. 2020

405

10;Available from: https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/

406

jiaa691/5943164.

407

29. Viner RM, Russell SJ, Croker H, Packer J, Ward J, Stansfield C, et al. School closure and

408

management practices during coronavirus outbreaks including COVID-19: a rapid systematic

409

review. The Lancet Child & Adolescent Health. 2020 5;4(5):397‚Äì404. Available from: https:

410

//linkinghub.elsevier.com/retrieve/pii/S235246422030095X.

411

30. Auger KA, Shah SS, Richardson T, Hartley D, Hall M, Warniment A, et al. Association

412

Between Statewide School Closure and COVID-19 Incidence and Mortality in the US. JAMA.

413

2020 9;324(9):859. Available from: https://jamanetwork.com/journals/jama/fullarticle/

414

2769034.

415

416

417

31. John J, Kang G. Public health during the pandemic in India. Science. 2020 11;370(6517):663‚Äì664.
Available from: https://www.sciencemag.org/lookup/doi/10.1126/science.abe9707.
32. Cori A, Ferguson NM, Fraser C, Cauchemez S. A New Framework and Software to Estimate

418

Time-Varying Reproduction Numbers During Epidemics. American Journal of Epidemiology.

419

2013 11;178(9):1505‚Äì1512. Available from: https://academic.oup.com/aje/article-lookup/

420

doi/10.1093/aje/kwt133.

421

33. Lehtinen S, Ashcroft P, Bonhoeffer S. On the relationship between serial interval, infectiousness

422

profile and generation time. medRxiv. 2020 9;Available from: https://doi.org/10.1101/2020.

423

09.18.20197210.

424

34. Soltesz K, Gustafsson F, Timpka T, Jald√©n J, Jidling C, Heimerson A, et al. The effect

425

of interventions on COVID-19. Nature. 2020 12;588(7839):E26‚ÄìE28. Available from: http:

426

//www.nature.com/articles/s41586-020-3025-y.

20/21

medRxiv preprint doi: https://doi.org/10.1101/2021.01.15.21249884; this version posted January 20, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

427

428

Acknowledgements We thank various people around the world for checking our data on nonpharmaceutical interventions.

429

Ethics approval Ethics approval was not required for this study.

430

Competing interests SF reports membership in a COVID-19 working group of the World Health

431

Organization but without competing interest. JPS declares part-time employment at Luciole

432

Medical outside of the submitted work. SF reports grants from the Swiss National Science

433

Foundation outside of the submitted work. All other authors declare no competing interests.

434

Funding NB, EvW and SF acknowledge funding from the Swiss National Science Foundation

435

(SNSF) as part of the Eccellenza grant 186932 on ‚ÄúData-driven health management‚Äù. The

436

funding bodies had no control over design, conduct, data, analysis, review, reporting, or

437

interpretation of the research conducted.

438

Contributions NB contributed to conceptualization, data collection, data analysis, results interpre-

439

tation and manuscript writing. EvW contributed to data collection and manuscript writing. AC,

440

AS, AC, BK, DT, JPS, and PB contributed to data collection. SL contributed to manuscript

441

writing. SF contributed to conceptualization, results interpretation and manuscript writing.

442

WV contributed to conceptualization, data analysis, results interpretation and manuscript

443

writing.

21/21

